Clinical Value for Diagnosis and Prognosis of Signal Sequence Receptor 1 (SSR1) and Its Potential Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on High-Throughput Data Analysis

References

• Kim DW, Talati C, Kim R. Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. J Gastrointest Oncol. 2017;8(2):256–265. doi:10.21037/jgo.2016.09.07
   PubMed Web of Science ®Google Scholar
• Chen J, Yang J, Xu Q, et al. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep. 2021;41(2). doi:10.1042/BSR20202063
   Web of Science ®Google Scholar
• Wang A, Chen X, Li D, Yang L, Jiang J. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis. J Clin Lab Anal. 2021;35:e23931.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang X, Cai XY, et al. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PeerJ. 2017;5:e3089. doi:10.7717/peerj.3089
   PubMed Web of Science ®Google Scholar
• Shi L, Shang X, Nie K, et al. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma. J Clin Pathol. 2021;74(8):504–512. doi:10.1136/jclinpath-2020-206979
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang L, Zhang Y, Li H. Circ-ATP5H induces hepatitis B virus replication and expression by regulating miR-138-5p/TNFAIP3 axis. Cancer Manag Res. 2020;12:11031–11040. doi:10.2147/CMAR.S272983
   PubMed Web of Science ®Google Scholar
• Chen G, Mo S, Yuan D. Upregulation mitochondrial carrier 1 (MTCH1) is associated with cell proliferation, invasion, and migration of liver hepatocellular carcinoma. Biomed Res Int. 2021;2021:9911784. doi:10.1155/2021/9911784
   PubMed Web of Science ®Google Scholar
• Abdel Samee NM, Solouma NH, Kadah YM. Detection of biomarkers for hepatocellular carcinoma using a hybrid univariate gene selection methods. Theor Biol Med Model. 2012;9:34. doi:10.1186/1742-4682-9-34
   PubMed Web of Science ®Google Scholar
• Luo J, Chen M, Huang H, et al. Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Onco Targets Ther. 2013;6:577–583.
   PubMed Web of Science ®Google Scholar
• Akada J, Kamei S, Ito A, et al. A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients. Proteome Sci. 2013;11(1):33. doi:10.1186/1477-5956-11-33
   PubMed Web of Science ®Google Scholar
• Huang S, Zhong W, Shi Z, et al. Overexpression of signal sequence receptor Î3 predicts poor survival in patients with hepatocellular carcinoma. Hum Pathol. 2018;81:47–54. doi:10.1016/j.humpath.2018.06.014
   PubMed Web of Science ®Google Scholar
• Yan J, Wang ZH, Yan Y, et al. RP11-156L14.1 regulates SSR1 expression by competitively binding to miR-548ao-3p in hypopharyngeal squamous cell carcinoma. Oncol Rep. 2020;44(5):2080–2092.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cao J, Pu YS, Ma Y, Wu M, Wang JH. RP11-874J12.4, a novel lncRNA, confers chemoresistance in human gastric cancer cells by sponging miR-3972 and upregulating SSR2 expression. Am J Transl Res. 2021;13(6):5892–5910.
   PubMed Web of Science ®Google Scholar
• Garg B, Pathria G, Wagner C, Maurer M, Wagner SN. Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress. Mutagenesis. 2016;31(5):573–582. doi:10.1093/mutage/gew023
   PubMed Web of Science ®Google Scholar
• Hong X, Luo H, Zhu G, et al. SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT. J Cancer. 2020;11(19):5578–5587. doi:10.7150/jca.44788
   PubMed Web of Science ®Google Scholar
• Funakoshi Y, Wang Y, Semba T, et al. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype. PLoS One. 2019;14(9):e0222336. doi:10.1371/journal.pone.0222336
   PubMed Web of Science ®Google Scholar
• Van Erk MJ, Teuling E, Staal YC, et al. Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog. 2004;3(1):8. doi:10.1186/1477-3163-3-8
   PubMedGoogle Scholar
• Liu Y, Yi Y, Wu W, Wu K, Zhang W. Bioinformatics prediction and analysis of hub genes and pathways of three types of gynecological cancer. Oncol Lett. 2019;18(1):617–628.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Wang F, Li X, Zhu X, Chen Q, Jiang L, Zhu Z. Renal tubular complement 3 deposition in children with primary nephrotic syndrome. Biomed Res Int. 2018;2018:4386438.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Guo J, Tang Q. Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma. Cancer Gene Ther. 2021. doi:10.1038/s41417-020-00259-4
   Web of Science ®Google Scholar
• Xiao S, Huang S, Yang J. Overexpression of GIHCG is associated with a poor prognosis and immune infiltration in hepatocellular carcinoma. Onco Targets Ther. 2020;13:11607–11619. doi:10.2147/OTT.S271966
   PubMed Web of Science ®Google Scholar
• Ju Z, Bhardwaj A, Embury MD, et al. Integrative analyses of multilevel omics reveal preneoplastic breast to possess a molecular landscape that is globally shared with invasive basal-like breast cancer (Running title: molecular landscape of basal-like breast cancer progression). Cancers. 2020;12(3):722.
   PubMed Web of Science ®Google Scholar
• Simerman AA, Phan JD, Dumesic DA, Chazenbalk GD. Muse cells: nontumorigenic pluripotent stem cells present in adult tissues-A paradigm shift in tissue regeneration and evolution. Stem Cells Int. 2016;2016:1463258. doi:10.1155/2016/1463258
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Buonaguro L, Izzo F, Buonaguro FM. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget. 2016;7(18):25087–25102. doi:10.18632/oncotarget.7837
   PubMedGoogle Scholar
• Mahajan UM, Teller S, Sendler M, et al. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Gut. 2016;65(11):1838–1849. doi:10.1136/gutjnl-2016-311393
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang P. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/Î2‑catenin signaling pathway. Oncol Rep. 2021;45(5). doi:10.3892/or.2021.8027
   Web of Science ®Google Scholar
• Lonetto G, Koifman G, Silberman A, et al. Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy. Cell Death Differ. 2019;26(9):1566–1581. doi:10.1038/s41418-018-0227-z
   PubMed Web of Science ®Google Scholar
• Yue Z, Guan X, Chao R, et al. Diallyl disulfide induces apoptosis and autophagy in human osteosarcoma MG-63 cells through the PI3K/Akt/mTOR pathway. Molecules. 2019;24(14):2665. doi:10.3390/molecules24142665
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang R, Feng C, et al. Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma. Oncol Rep. 2014;32(4):1748–1756. doi:10.3892/or.2014.3361
   PubMed Web of Science ®Google Scholar